Arena Pharmaceuticals Inc (ARNA)

45.80 +0.38  +0.84% NASDAQ Jan 22, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/26/2020 16:30 EST Misc Arena Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2019
02/26/2020 Earnings Arena Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
11/07/2019 16:30 EST Misc Arena Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/07/2019 Earnings Arena Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
08/07/2019 16:30 EDT Misc Arena Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Arena Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
06/13/2019 09:00 PDT Misc Arena Pharmaceuticals Inc Annual General Meeting in 2018
05/08/2019 16:30 EDT Misc Arena Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Arena Pharmaceuticals Inc First Quarter Earnings in 2019 Release
02/28/2019 Misc Arena Pharmaceuticals Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.arenapharm.com
  • Investor Relations URL: http://invest.arenapharm.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 26, 2020
  • Last Earnings Release: Nov. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Top Fund Holders

Symbol Name Weighting
YOLO AdvisorShares Pure Cannabis ETF 3.31%
F000011I5F FT SMid Biotechnology Portfolio 4 F CA 3.15%
SLIM The Obesity ETF 2.79%
CANNX Cannabis Growth Investor 2.67%
DLRHX Delaware Healthcare R 2.43%
SBIO ALPS Medical Breakthroughs ETF 2.09%
MJ ETFMG Alternative Harvest ETF 1.93%
KRXCX Kinetics Medical Adv C 1.32%
NSNRX Neuberger Berman Small Cap Growth R3 1.23%
MXSVX Great-West Invesco Small Cap Value Inv 0.90%
AVUV Avantis™ U.S. Small Cap Value ETF 0.60%
GSSC Goldman Sachs ActiveBeta® US SmCp Eq ETF 0.23%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.